Here are the 10-K annual reports from Utah Medical Products Inc (UTMD) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow UTMD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UTMD filings page.
Utah Medical Products reported 2025 revenue of $38.5 million, down 5.8% from 2024, as several key customers reduced orders or exited. Net income fell 18.7% to $11.3 million, and GAAP EPS declined 12.1% to $3.483, reflecting lower sales and higher operating costs.
The sharpest hit came from OEM customer PendoTECH and a Chinese distributor that canceled part of its 2025 order and left a receivable that was written off. Filshie device revenue slipped overall, though U.S. hospital sales grew. Even with these pressures, UTMD maintained gross margin above 57% and ended the year with $85.8 million in cash after paying dividends and repurchasing about 4.5% of its shares.